25 April Preliminary FY 2017 revenue and other income of £4.1 Million
24 April Consolidation of US R&D activities and Board change
Collagen-Based Spray Adhesive Shows Promising Data for Wound Care Applications
03 April Holding(s) in Company
03 April Agreement signed with Smart Matrix Limited
31 March Holding(s) in Company
29 March Collagen Solutions granted Australian Divisional Patent for Pericardium
27 March Issue of Equity and Director/PDMR Shareholding
24 March Director/PDMR Dealing
23 March UK Investor Show 2017 attendance
20 March Collagen Solutions introduces new online sales initiative in the US
15 March Holding(s) in Company
14 March Holding(s) in Company
13 March Holding(s) in Company
13 March Hardman Research: Engineering cartilage repairs
09 March Holding(s) in Company
09 March Holding(s) in Company
09 March Collagen Solutions attends AAOS and ORS Meetings in San Diego
Support for Brain Awareness Week 13-19 March
08 March Grant of Options
07 March Holding(s) in Company
07 March Director/PDMR Dealing
07 March Holding(s) in Company
07 March Holding(s) in Company
06 March Result of General Meeting and Open Offer
20 February Investor Presentation
15 February Grant of Options
14 February Norgine Ventures completes £4 million financing with Collagen Solutions (Press Release)
14 February Hardman Research: Funding accelerated growth
14 February Conditional Placing and Open Offer to raise up to £8.0 million
Conditional issue of up to £4.0 million in senior secured private bonds with warrants
and Notice of General Meeting
07 February Collagen Solutions at the Medical Design and Manufacturing West Conference in Anaheim 7-9 February
19 January Team Strengthened with New Scientific Advisory Board Appointments
13 January Awarded third Medical Research Scotland Ph.D. Studentship